Alivus Life Sciences Profit & Loss Annual

BSE: - | NSE: - | ISIN: - | Sector: -

913.30 +23.35 (2.62%)Updated : 15 Dec 2025

Interim Data

Annual Data

Fiscal Period	2025	2024	2023	2022
Period End Date	Mar 25	Mar 24	Mar 23	Mar 22
Total Operating Expense	1,763.09	1,661.08	1,560.46	1,543.97
Other Net	3.28	0.00	0.14	-0.07
Diluted Weighted Average Shares	12.29	12.27	12.25	11.75
Gain( Loss)on Saleof Assets	-1.82	-0.70	-0.56	-0.74
Depreciation/ Amortization	60.61	53.45	42.09	37.88
Operating Income	623.80	622.14	600.76	579.25
Net Income	485.63	470.89	466.96	418.72
Income Availableto Com Excl Extra Ord	485.63	470.89	466.96	418.72
Other Operating Expenses Total	22.91	29.55	25.57	-0.32
Net Income Before Taxes	654.13	631.29	628.61	564.93
Net Income After Taxes	485.63	470.89	466.96	418.72
Income Availableto Com Incl Extra Ord	485.63	470.89	466.96	418.72
Costof Revenue Total	1,099.13	1,002.01	1,014.09	1,042.89
Gross Profit	1,287.76	1,281.20	1,147.13	1,080.33
Interest Inc( Exp) Net- Non- Op Total	28.88	9.86	28.27	-13.51
Diluted Net Income	485.63	470.89	466.96	418.72
DPS- Common Stock Primary Issue	5.00	22.50	21.00	21.00
Provisionfor Income Taxes	168.50	160.40	161.65	146.20
period Type	-	-	-	-
Net Income Before Extra Items	485.63	470.89	466.96	418.72
Total Revenue	2,386.88	2,283.21	2,161.22	2,123.21
period Length	12.00	12.00	12.00	12.00
Revenue	2,386.88	2,283.21	2,161.22	2,123.21
Selling/ General/ Admin Expenses Total	580.44	576.07	478.71	463.52
Diluted Normalized EPS	39.63	38.43	38.14	35.67
Diluted EPS Excluding Extra Ord Items	39.52	38.38	38.11	35.63

*All figures in crores except per share values

Trending Stocks

2,290.15+29.10(1.29%)

4,123.65+50.70(1.24%)

1,683.80+11.40(0.68%)

3,608.85-70.05 (-1.90%)

2,068.55-17.45 (-0.84%)

Related News